Correlation of CEA levels with metabolic tumor volume, assessed by FDG PET and RECIST complient size measurement in patients with recurrent and/or metastatic colorectal cancer

被引：0
|
作者：
Bochev, P. [1 ]
Bocheva, Y. [2 ]
Mateva, G. [1 ]
机构：
[1] Acibadem Cityclin UMBAL Mladost Oncol Hosp, Sofia, Bulgaria
[2] Med Univ Prof Dr Paraskev Stoyanov, Varna, Bulgaria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-031
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [1] Correlation of CEA levels and metabolic tumor volume in patients with recurrent and/or metastatic colorectal cancer
    Bochev, P.
    Bocheva, Y.
    Mateva, G.
    Valchanova, I.
    CLINICA CHIMICA ACTA, 2022, 530 : S54 - S54
  • [2] Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer
    Mi Yeon Choi
    Kwang Min Lee
    June-Key Chung
    Dong Soo Lee
    Jae Min Jeong
    Jae Gahb Park
    Jung-Hoe Kim
    Myung Chul Lee
    Annals of Nuclear Medicine, 2005, 19 : 123 - 129
  • [3] Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer
    Choi, MY
    Lee, KM
    Chung, JK
    Lee, DS
    Jeong, JM
    Park, JG
    Kim, JH
    Lee, MC
    ANNALS OF NUCLEAR MEDICINE, 2005, 19 (02) : 123 - 129
  • [4] FDG-PET imaging in detecting recurrent or metastatic colorectal cancer in patients with elevated CEA levels
    Ponzo, F
    Zhuang, HM
    Lacorte, LB
    Alavi, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1017 - 1017
  • [5] Is there a relationship between CEA levels and FDG-PET/CT findings in patients with recurrent colorectal cancer?
    Sanli, Yasemin
    Kadioglu, Nilgun
    Turkmen, Cuneyt
    Asoglu, Oktar
    Unal, Seher
    Adalet, Isik
    Kuyumcu, Serkan
    Mudun, Ayse
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [6] Detection of recurrent colorectal cancer by FDG PET in patients with serum CEA elevation
    Valk, PE
    Abella-Columna, E
    Tesar, RD
    Pounds, TR
    Haseman, MK
    Myers, RW
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 135P - 135P
  • [7] Correlation of FDG PET-CT quantitative parameters (SUVmax, metabolic tumor volume, total lesion glycolysis) with serum tumor markers in recurrent colorectal cancer
    Caglar, M.
    Unlu, M.
    Karabulut, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S335 - S335
  • [8] ASSESSING TUMOR RESPONSE TO CHEMOTHERAPY IN PEDIATRIC METASTATIC COLORECTAL CANCER: THE USE OF CEA AND FDG-PET/CT
    Drezner, Nicole
    Doros, Leslie
    Rossi, Chris
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S82 - S82
  • [9] Comparison of predictive value betweenmetabolic tumor volume and RECIST 1.1 assessed by 18F-FDG PET-CT in patients with lung cancer
    Lin, J-T.
    Hou, Q-Y.
    Dong, Z-Y.
    Zhong, W-Z.
    Li, Y-S.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] Correlation between TNM staging and tumor metabolic parameters assessed in vivo by FDG-PET/CT in patients with lung cancer
    Cegla, P.
    Tyczynska, K.
    Czepczynski, R.
    Cholewinski, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S86 - S86
12345